Clinical trial
A Prospective Multi-center Clinical Study Evaluating the Use of PD G 506 A and the Eagle V1.2 Imaging System for the Visualization of Carcinoma During Breast Conserving Surgery
NCT04815083 is registered in ClinicalTrials.gov with SBI ALApharma Canada, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Multi-center Clinical Study Evaluating the Use of PD G 506 A and the Eagle V1.2 Imaging System for the Visualization of Carcinoma During Breast Conserving Surgery
- Lead sponsor
- SBI ALApharma Canada, Inc.
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- April 27, 2021
- Completion date
- December 20, 2024
- Enrollment
- 57 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, breast neoplasm female